ITM Isotopen Technologien München AG


    • Company type:
      • Manufacturer
      • Research & Development
    • Year founded:
    • 2005
    • Employees (at the site):
    • 40
    • Turnover range:
    • <5m EUR
    • Products/services:
    • The ITM Group provides a new generation of highly effective radioisotope therapies and integrated application systems to those oncological and endovascular patients who are currently very difficult or impossible to treat with conventional methods:
      ITM-Rhenium-SCT©: Skin cancer patients with large and difficult to treat lesions
      ITM-Rhenium-PTA©: Diabetic patients with progressed peripheral endovascular disease. Cardiovascular patients with recurring in-stent restenosis
      PRRT: Peptide Receptor Radioisotope Therapies: Oncological patients with diffuse metastatic disease.
      Through the development of integrated, proprietary application systems and controlling the supply processes from radioisotope production (Lu-177, Ga-68, Re-188 etc) and logistics to patient administration, new levels in radiation safety, convenience, service and medical efficiency in these Radiopharmaceutical and Brachytherapeutical Applications are attained and brought to the global clinical environment.

    • Core competencies:
    • not available

    • Language skills:
    • English
    • Key Tech / section:
      • Biotechnology: Information systems for biotechnology
      • Chemical Industry: Inorganic basic chemicals
      • Cultural and Creative Industries: Software and games
      • Information Technology: Software for industry
      • Medical Technology: Cardiology
      • Medical Technology: Dermatology, allergology
      • Medical Technology: Medical Technology
      • Medical Technology: Nuclear medicine
    • Industries NACE:
      • 72: Scientific research and development
    • Certification:
    • not available

    • Sales markets - target industries:
    • not available
    • Sales markets - target countries:
    • not available
    • Cooperation offers:
    • not available
    • Contact person:
    • Dr. Konstantin Zhernosekov (Mr.)
      - Management
      - Sales / marketing
      - Cooperation

      Dr. Richard Henkelmann (Mr.)
      - Management
      - Sales / marketing
      - Cooperation